about us

Augustine Therapeutics focuses on the discovery and development of innovative medicines to benefit patients suffering from Charcot-Marie-Tooth disease (CMT) and other neuromuscular diseases. The newly formed company is rooted in the ground-breaking research at VIB and KU Leuven and supported by V-Bio Ventures, PMV, Advent France Biotechnology and Gemma Frisius Fund. ​

Board of Directors​

 

info

 

info

 
info

Ward
Capoen

job description

Jerome
Van Biervliet

Job title & Description

David
Devigne

Job Title & Description

Therapeutics

for neuromuscular

diseases 

 

info

Alain
Huriez

Job Title

 

info

BART
geers

Job Title & Description

Fund boiler plates​